Genomic risk prediction of type 2 diabetes in a clinical trial setting

被引:0
|
作者
Jiang, Xiao [1 ]
Nag, Abhishek [1 ]
Smith, Katherine [1 ]
Challis, Benjamin [2 ]
Ambery, Philip [3 ]
Carlsson, Bjorn [2 ]
Oscarsson, Jan [3 ]
Paul, Dirk [1 ]
机构
[1] AstraZeneca, BioPharmaceut R&D, Ctr Genom Res Discovery Sci, Cambridge, England
[2] AstraZeneca, BioPharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden
[3] AstraZeneca, BioPharmaceut R&D, Latestage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
EP07.034
引用
收藏
页码:159 / 159
页数:1
相关论文
共 50 条
  • [1] Insomnia is associated with an increased risk of type 2 diabetes in the clinical setting
    LeBlanc, Erin S.
    Smith, Ning X.
    Nichols, Gregory A.
    Allison, Michael J.
    Clarke, Gregory N.
    BMJ OPEN DIABETES RESEARCH & CARE, 2018, 6 (01)
  • [2] Insomnia Is Associated with an Increased Risk of Type 2 Diabetes in the Clinical Setting
    Leblanc, Erin
    Smith, Ning
    Allison, Michael
    Nichols, Gregory
    Clarke, Greg
    DIABETES, 2018, 67
  • [3] Biomarkers in type 1 diabetes: application to the clinical trial setting
    Tooley, James E.
    Herold, Kevan C.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (04) : 287 - 292
  • [4] Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care setting
    Dziopa, K. D.
    Asselbergs, F. W. A.
    Gratton, J. G.
    Chaturvedi, N. C.
    Schmidt, A. F. S.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2458 - 2458
  • [5] Comparisons of Polyexposure, Polygenic, and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes
    He, Yixuan
    Lakhani, Chirag M.
    Rasooly, Danielle
    Manrai, Arjun K.
    Tzoulaki, Ioanna
    Patel, Chirag J.
    DIABETES CARE, 2021, 44 (04) : 935 - 943
  • [6] Genomic risk prediction of cardiovascular diseases among type 2 diabetes patients in the UK Biobank
    Ye, Yixuan
    Hu, Jiaqi
    Pang, Fuyuan
    Cui, Can
    Zhao, Hongyu
    FRONTIERS IN BIOINFORMATICS, 2024, 3
  • [7] Clinical Trial Risk in Type-2 Diabetes: Importance of Patient History
    Aiyere, Emmanuel O.
    Silverberg, Jay
    Ali, Safina
    Parker, Jayson L.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (03): : 393 - 400
  • [8] Improving risk prediction of type 2 diabetes
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (01) : 14 - 14
  • [9] Individualized Type 2 Diabetes Risk Prediction
    Jaeger, Byron C.
    Wells, Brian J.
    Stafford, Jeanette M.
    Casanova, Ramon
    Demesie, Yitbarek
    Bancks, Michael
    DIABETES, 2024, 73
  • [10] Biomarkers and risk prediction of type 2 diabetes
    Schulze, M. B.
    Kowall, B.
    Rathmann, W.
    DIABETOLOGE, 2012, 8 (01): : 18 - +